Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy

NACompletedINTERVENTIONAL
Enrollment

288

Participants

Timeline

Start Date

September 29, 2021

Primary Completion Date

September 29, 2022

Study Completion Date

November 30, 2022

Conditions
Diagnoses DiseaseScreeningHSIL of CervixCervical Cancer
Interventions
DIAGNOSTIC_TEST

Endocervical liquid-base cytology

Endocervical sample collected by brushing and preserved in a liquid-base.

DIAGNOSTIC_TEST

Endocervical cell block

"Endocervical sample collected by endocervical brush and preserved in a buffered formalin base for obtaining a cell block and evaluated as histology."

DIAGNOSTIC_TEST

Endocervical curettage

Endocervical sample obtained by curettage, preserved in buffered formalin, and evaluated as histology.

Trial Locations (4)

13036225

Hospital de Cancer de Barretos, Campinas

14784400

Hospital de Cancer de Barretos, Barretos

79085040

Hospital de Cancer de Barretos, Campo Grande

79750000

Sandra Moretti Jusselino Maniçoba Palopoli, Nova Andradina

All Listed Sponsors
lead

Cirbia Silva Campos Teixeira

OTHER

NCT05120167 - Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy | Biotech Hunter | Biotech Hunter